Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Value of Exome and Genome Sequencing as Well as Conventional Methods in Rare Diseases and Familial Tumor Syndromes

NCT04731857 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT04731857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04731857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Value of Exome and Genome Sequencing as Well as Conventional Methods in Rare Diseases and Familial Tumor Syndromes
Lead sponsor
University Hospital Tuebingen
Phase
Observational
Overall status
Recruiting
Start date
February 18, 2021
Completion date
February 28, 2031
Enrollment
12,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetic predisposition, rare diseases